Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
August 30, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit
August 29, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
August 13, 2018 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13
August 06, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care,...
Cesca Therapeutics Announces the Launch of its PXP™ System for Automated Processing of Bone Marrow Cells
July 16, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
June 06, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
Cesca Therapeutics Announces Reduction in Operating Expenses
June 04, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy
May 23, 2018 08:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
Cesca Announces Closing of $5.5 Million Public Offering
May 18, 2018 11:12 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 18, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
Cesca Prices $5.5 Million Public Offering
May 16, 2018 12:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...